Swedish Biotech Breakthroughs

Xbrane Biopharma

Market Cap: SEK 410.6m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Guard Therapeutics International

Market Cap: SEK 407.4m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

Lipigon Pharmaceuticals

Market Cap: SEK 22.3m

Develops drugs for lipid related diseases in Sweden.

Devyser Diagnostics

Market Cap: SEK 2.2b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Egetis Therapeutics

Market Cap: SEK 2.0b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

BioInvent International

Market Cap: SEK 2.5b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Active Biotech

Market Cap: SEK 261.4m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Diamyd Medical

Market Cap: SEK 1.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Mendus

Market Cap: SEK 404.2m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Initiator Pharma

Market Cap: SEK 224.5m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.